Intracerebroventricular administration of a modified hexosaminidase ameliorates late-stage neurodegeneration in a GM2 mouse model - Manuel E. Lopez; Daniel Wendt; Roger Lawrence; Kerui Gong; Hoonsan Ong; Bryan Yip; Joseph Chen; Linley Mangini; Britta Handyside; Alexander Giaramita; Aashish Lamichhane; Melanie Lo; et al. (PLoS ONE, 2025)